see also:

• fungi
• antifungal agents

• Candida sp is a yeast and the main human pathogen in the Candida family has been C. albicans but in 2009, a new species, C. auris was discovered and this organism appears to be developing into a global threat for at risk critically ill hospitalised patients

• a very common pathogen which is the cause of oral, vaginal and moist skin fold thrush
  • see also wearing underwear - health benefits and adverse effects
• may also cause systemic infection in immunocompromised patients and those with long term vascular lines in situ

• discovered in 2009
• can be resistant to all four major classes of antifungal agents
• may cause systemic infection in immunocompromised patients and those with long term vascular lines in situ
• mortality rate from systemic infections is 30-50%
• was discovered for 1st time in Brazil in 2021
• in 2023, there were over 4500 cases in the US and the US FDA approved Rezafungin for invasive Candida infections.
• by 2025, it had been documented in hospitals in over 50 countries